Clinical Trial Update: A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CK-2017357 in patients with intermittent claudication due to peripheral artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• CK-2017357

Snippet

Sponsor: Cytokinetics | Conditions: Intermittent Claudication, Peripheral Artery Disease | Phase 2 | Status: COMPLETED